Furthermore, the high expression of EphB2 indicated a better response rate to Qingyihuaji formula (QYHJ) treatment in pancreatic cancer CFPAC-1 cells (Hua et al., 2011; Hua et al., 2014), but the contradictory results need more thorough research. The gene discussed is EPHB2; the disease is familial pancreatic carcinoma.